Manuel Fernández-Bruno

Statistics

Publications

Citations

142

H-Index

Active since

2018

Affiliations

Instituto Oncológico Dr. Rosell(Current)

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

USP Institut Universitari Dexeus

Pivotal (Spain)

Institut Català d'Oncologia

Manuel Fernández-Bruno is an author at Instituto Oncológico Dr. Rosell specializing in oncology, non-small cell lung cancer therapy, and non-small cell lung cancer treatment.

Publications per year

2018–2019

Publications

BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Trever G. Bivona et al. · Cancers · 2019 · 68 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)

Niki Karachaliou, Andrés F. Cardona, Jillian Wilhelmina Paulina Bracht et al. · EBioMedicine · 2018 · 44 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

EGFR first- and second-generation TKIs—there is still place for them in EGFR -mutant NSCLC patients

Niki Karachaliou, Manuel Fernández-Bruno, Jillian Wilhelmina Paulina Bracht et al. · Translational Cancer Research · 2018 · 18 citations

Medicine, Oncology, Pharmacology +16

PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer

Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Jordi Berenguer et al. · Journal of Cancer Metastasis and Treatment · 2019 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4